Michelle N Chesnut, MD | |
8210 Walnut Hill Ln, Suite 314, Dallas, TX 75231-4405 | |
(214) 432-1616 | |
(214) 432-1617 |
Full Name | Michelle N Chesnut |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 26 Years |
Location | 8210 Walnut Hill Ln, Dallas, Texas |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760411979 | NPI | - | NPPES |
209382902 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 2004024746 (Missouri) | Primary |
207RP1001X | Internal Medicine - Pulmonary Disease | 2004024746 (Missouri) | Secondary |
Entity Name | Michelle Chesnut, Md, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255596581 PECOS PAC ID: 6507926268 Enrollment ID: O20081125000642 |
News Archive
A population-based study revealed reasons behind elevated suicide risk, attempted suicides, and other selfharm, which require special health care, among a and young adults with autism spectrum disorders. Comorbid disorders, especially non-affective psychoses and the affective and anxiety disorders, explained the risk.
Hospital readmission, an important measure of quality care, costs the United States an estimated $17 billion each year. And according to the Centers for Medicare and Medicaid Services, about half of those readmissions could be avoided.
People with a history of cancer have an over two-fold risk of developing atrial fibrillation (AFib), the most common heart rhythm disorder, compared to the general population, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
The David Geffen School of Medicine at UCLA is one of six institutions nationwide chosen by the National Institutes of Health to join their effort in tackling the most difficult-to-solve medical cases and develop ways to diagnose rare genetic disorders.
Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michelle N Chesnut, MD 8210 Walnut Hill Ln, Suite 314, Dallas, TX 75231-4405 Ph: (214) 432-1616 | Michelle N Chesnut, MD 8210 Walnut Hill Ln, Suite 314, Dallas, TX 75231-4405 Ph: (214) 432-1616 |
News Archive
A population-based study revealed reasons behind elevated suicide risk, attempted suicides, and other selfharm, which require special health care, among a and young adults with autism spectrum disorders. Comorbid disorders, especially non-affective psychoses and the affective and anxiety disorders, explained the risk.
Hospital readmission, an important measure of quality care, costs the United States an estimated $17 billion each year. And according to the Centers for Medicare and Medicaid Services, about half of those readmissions could be avoided.
People with a history of cancer have an over two-fold risk of developing atrial fibrillation (AFib), the most common heart rhythm disorder, compared to the general population, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
The David Geffen School of Medicine at UCLA is one of six institutions nationwide chosen by the National Institutes of Health to join their effort in tackling the most difficult-to-solve medical cases and develop ways to diagnose rare genetic disorders.
Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.
› Verified 8 days ago
Uma B.r.k Pakkivenkata, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |